July 2, 2026
Patent due diligence: a transaction evidence checklist
Review patent records, claims, families, and deal documents with a transaction-focused diligence checklist, sample evidence register, and escalation questions.

Which patent assets support the technology and markets behind your proposed transaction, and which questions remain open before signing or closing? A portfolio count cannot answer that question. You need to connect individual patent records, claim versions, product evidence, and transaction documents.
A useful patent due diligence checklist turns those connections into a record your deal team can act on, with clear priorities, missing evidence, and responsibility for resolution.
Scope: transaction-focused patent evidence review across U.S., European, and international filings.
What patent due diligence should deliver
Patent due diligence examines specified patent assets in the context of an acquisition, investment, financing, or license. Its practical deliverable is a supported account of what the transaction includes, what the records and claims show, and which unresolved issues affect the proposed use of those assets.
Keep its purpose separate from neighboring work:
- A recurring patent portfolio review supports ongoing management and resource allocation. Transaction diligence has a defined deal perimeter and decision deadline.
- A patentability assessment addresses whether an invention may qualify for patent protection. A transaction may instead require focused validity analysis of existing claims.
- A freedom-to-operate analysis examines third-party patent risk for specified product activity, territories, and dates. Record that work as a separate workstream when the deal requires it.
Organize the handoff around an asset schedule, an evidence register, and an issue list. Keep a recorded fact, a missing document, and a legal question in separate fields.
The transaction-focused patent due diligence checklist
1. Set the transaction perimeter and review depth
Write down the deal structure, included assets, relevant products, intended activities, territories, and signing and closing milestones. Identify the business propositions that require patent support, such as a core manufacturing process or a planned market entry.
| Transaction context | Priority evidence | Question for the deal team |
|---|---|---|
| Company acquisition or merger | Core-product families, relevant agreements, proceedings, and upcoming deadlines | Which patent-related assumptions underpin the operating plan after closing? |
| Patent asset acquisition | Member-by-member asset schedule, exact claims, related pending applications, and included documents | Which grants and applications are expressly within the transaction perimeter? |
| Investment or financing | Evidence supporting technology claims, prosecution status, material agreements, and near-term obligations | Which assumptions need resolution before the investment decision? |
| License | Scheduled patents and applications, territories, claim-to-technology evidence, and executed agreements | How do the proposed activities and territories align with the rights described in the agreement? |
Separate a baseline record review from deeper claim analysis. Prioritize assets tied to the deal rationale, imminent deadlines, active disputes, or conflicting evidence. Record which assets receive only a baseline review and why.
Group the schedule using your team's technology and product categories. Compare those groups with the acquisition's product roadmap, and flag assets with weak or no documented product relationship for deeper claim-relevance review.
2. Reconcile the asset schedule and patent families
Create a row for each application or granted patent, with its application, publication, and grant identifiers as applicable. Record jurisdiction, document type, filing and claimed priority dates, family reference, and inclusion in the deal schedule. Reconcile seller-supplied schedules against office records and the supplied docket report. Retain discrepancies as open items.
A patent family groups related applications through priority claims. The European Patent Office (EPO) explains that family definitions differ across databases. Record the family source and definition, then review the relevant members individually for claims, territory, and status.
Include related pending applications, continuations, and divisionals in the reconciliation. Separate a claimed priority relationship from a question about whether a particular claim receives the benefit of an earlier filing.
For Patent Cooperation Treaty (PCT) filings, trace the international application to the national or regional members relevant to the deal. A WO publication identifies an international application. Under the PCT filing procedure, patent grants remain with national or regional offices. List the actual members supporting each target territory.

3. Confirm record status in the relevant jurisdiction
Capture the source, record identifier, retrieval date, status wording, and supporting event or document. Reconcile that snapshot with fee receipts, docket entries, and newly supplied filings.
| Asset or proceeding | Evidence to collect |
|---|---|
| U.S. application or grant | Patent Center status, relevant filings, issued documents, fee records, and identified post-grant proceedings. Record each source independently and distinguish pending, allowed, issued, abandoned, and post-grant events. |
| European patent application or EPO proceeding | European Patent Register views and relevant documents, including opposition, limitation, or revocation material. Record the procedural stage and affected claim version. |
| European patent after grant | Relevant national register records and, where applicable, Unitary Patent information identifying the national territories or unitary coverage involved. |
| PCT international application | Published application, search and examination materials, and identified national or regional files, organized separately for the international phase and each national or regional member. |
| Other national assets | The relevant patent-office register, local documents, and applicable fee information, recorded using that jurisdiction's procedures and terminology. |
The EPO distinguishes its own proceedings from supplementary national-phase information. Its register guidance directs readers to national authorities for national legal information. Record the relevant national checks alongside the European record. For Unitary Patents, capture the participating territories covered at registration of unitary effect.
For U.S. assets, the U.S. Patent and Trademark Office (USPTO) warns that newly filed documents may take time to appear in Patent Center. Preserve the filing receipt and filed document when a recent submission explains a mismatch.
Review fees and deadlines by asset type and jurisdiction. U.S. maintenance fee requirements apply to specified utility and reissue utility patents; design and plant patents have no such maintenance fees. Record payment evidence, the next applicable deadline, and any lapse or restoration issue. Route remaining-term calculations with their supporting dates and adjustments for asset-specific review.
4. Read the exact claims against the transaction's technology
For each priority asset, identify the independent claims and any dependent claims relevant to the deal rationale. Capture the claim numbers, document date, language, and version: published, pending as amended, granted, or amended after grant.
Build the comparison at the claim-limitation level. A limitation is a required feature or condition within a claim. For each limitation, record the supporting technical passage, drawing, measurement, or other evidence, together with any gap. Use dated product specifications and process descriptions that correspond to the business activity being assessed.
Keep these observations distinct:
- Technical relevance: the patent concerns the same technology area.
- Claim mapping: identified evidence corresponds to particular claim limitations.
- Open scope question: interpretation, missing technical evidence, or a different claim version could change the analysis.
For European patents, Article 69 of the European Patent Convention ties the extent of protection to the claims, interpreted using the description and drawings, and addresses granted or amended claims. Identify any proceedings that affect the claim text before carrying a product comparison into the deal summary.
Record prior-art or validity concerns as defined issues: the affected claim, reference, relevant dates, and unresolved proposition. Keep a title-level similarity or an initial search hit in the screening record until the necessary claim-level analysis is complete.
5. Assemble the documents behind each finding
Use a document request list linked to asset and issue identifiers. Request the materials relevant to the agreed scope:
- Patent publications, grants, specifications, drawings, and the claim versions used in the analysis.
- Priority documents and relevant continuation, divisional, and national or regional filing records.
- Examination communications, amendments, responses, and decisions affecting the selected claims.
- Maintenance or renewal receipts, docket reports, deadline correspondence, and any lapse or restoration documents.
- Relevant executed licenses, amendments, covenants, settlement documents, and other transaction-related agreements, with their schedules and exhibits.
- Documents for identified litigation, oppositions, post-grant challenges, or other material proceedings.
- Dated technical materials supporting the claimed product or process relationship.
Reconcile patent identifiers and party names across the schedules, recorded transaction documents, and supplied agreements. Flag missing signatures, schedules, or exhibits for document follow-up without converting the discrepancy into a legal conclusion.
Account separately for nonpublic material. Patent Center's public access scope covers issued patents and published applications; private access has separate requirements. Obtain authorized seller-supplied materials for the nonpublic pipeline and record any access gap.
Label document provenance accurately. Downloaded application-file documents and certified copies are different evidence types. The USPTO provides uncertified electronic copies when available and a separate certified-copy service. Record which form the transaction requires and which form has been obtained.
6. Escalate issues as questions that can be resolved
Give each issue an affected asset, evidence reference, business consequence, responsible reviewer, required response, and due date. Escalate imminent deadlines and evidence that contradicts a material deal assumption promptly. Separate those issues from routine document requests, and identify which questions need resolution before signing or closing. Use concrete questions:
- Status conflict: Which event and supporting document resolve the difference between the seller's schedule and the office record?
- Claim-version conflict: Which claims govern the analysis after the identified amendment or proceeding?
- Technical gap: What evidence addresses the unmapped limitation for the product version within scope?
- Territorial gap: Which national member or unitary coverage supports the planned activity in the specified market?
- Agreement restriction: How do the agreement's field, territory, exclusivity, consent, or change-of-control provisions affect the proposed transaction?
- Validity concern: What claim-specific analysis is needed to resolve the identified reference or procedural issue?
Route technical evidence requests to the relevant engineering lead, record and deadline discrepancies to the patent team, and agreement questions to transaction counsel. Assign jurisdiction-specific legal questions to the appropriate patent counsel. The issue list should show the response needed and the transaction milestone it affects.
A sample patent diligence evidence register
Use one row per asset-specific question, allowing several rows for a single member. Include actual office identifiers in a live register and connect related rows through a family ID. Preserve the source file or stable record link, a page or event locator, retrieval date, reviewer, and resolution evidence.
Fictional 2026 example: internal member labels stand in for office identifiers.
| Evidence ID and member | Deal question and exact version | Source, locator, and retrieval | Recorded fact or evidence gap | Action, lead, and deadline | Disposition |
|---|---|---|---|---|---|
| E-01; F-01 / US-A; United States | Core file-synchronization method; March 3, 2026 grant, claim 1 | US-A grant, p. 12; file-synchronization specification R3, section 4.2; retrieved October 5, 2026 | Claim requires a content-hash comparison before uploading a changed file. Supplied specification describes file synchronization but omits that comparison step. | Engineering lead: supply dated process evidence by October 8; patent counsel: resolve scope question by October 12. | Open: technical evidence requested; no coverage conclusion recorded. |
| E-02; F-01 / EP-A; Germany | Planned German activity; claim 1 amended in opposition | EPO decision dated September 10, 2026, annex p. 2; retrieved October 5, 2026 | Amended text obtained. German national-status evidence missing from the file. | Patent team: obtain national record; German patent counsel: resolve claim/status implications by October 12. | Open: national evidence and analysis outstanding. |
| E-03; F-02 / PCT-A; international phase | Proposed Canadian license territory; published claims 1–8 | PCT publication and seller schedule v2, row 19; retrieved October 5, 2026 | Schedule lists the international application. Canadian member identifier and file documents remain missing. | Seller liaison: provide member details by October 8; Canadian patent counsel: resolve territorial question by October 12. | Open: territory support unresolved. |
| E-04; F-03 / US-B; United States | Maintenance payment evidence at cutoff | USPTO payment statement, October 2 entry; receipt R-04; retrieved October 5, 2026 | Statement and receipt identify the same patent, application, and payment. | Patent operations lead: reconcile payment documents by October 7. | Closed October 7 by patent operations lead; statement and R-04 retained. |
A closed row should identify the document received, the response, the reviewer, and the closure date. If the team accepts an unresolved issue for a particular transaction milestone, preserve that decision and its remaining conditions in the register.
Close the diligence handoff
Prepare a short decision summary supported by the register. State the assets and jurisdictions reviewed, depth of analysis, evidence cutoff, material findings, unresolved issues, and responsibilities before the next deal milestone. Identify excluded assets and missing materials explicitly.
Refresh time-sensitive records near the relevant milestone, especially where filings, proceedings, or payments have changed since collection. Preserve earlier snapshots so the team can explain what changed.
Where Patlytics fits
Classification applies your team's taxonomy to assets in Patent Vault, organizing the transaction perimeter into technology and product groups. Patlytics connects that portfolio organization with the patent-to-product and claim-level evidence work required for intellectual property due diligence in mergers and acquisitions:
- Clustering groups related patents by technology. Portfolio Heatmaps display patent-to-product results within those groups to prioritize deeper claim review.
- Portfolio Analysis maps patents to products across the portfolio, supplying evidence for the product relationships assessed in step 4.
- Patent Pruning uses portfolio-level patent-to-product mapping to surface assets with weak or no current product coverage for the claim-relevance assessment defined in step 1.
- Infringement Detection Reports find public product evidence for selected claims and generate limitation-by-limitation claim charts with cited disclosures. Exhaustive mode provides deeper coverage on selected priority claims.
- Claim Construction proposes constructions with pin cites to the specification. The constructions are editable, and edits re-run the chart for the claim-scope questions in step 4.
- Patent & NPL Search searches patents and non-patent literature (NPL), including PubMed, for the defined prior-art questions. Invalidity claim charts organize cited references against claim limitations. Word and Excel exports support the evidence handoff.
Attorneys review all outputs and retain authority over legal conclusions.
Build a claim-linked view of the patent assets behind your transaction with Patlytics. Book a demo.
See it on your own patents
Reduce cycle times. Increase margins. Deliver winning IP outcomes.


















































